Oseltamivir

Neuraminidase inhibitors

ATC code: J05AH02 (Oseltamivir)

Mechanism of action

Prodrug. Converted in the liver to oseltamivir carboxylate, which selectively inhibits influenza A and B neuraminidase. Neuraminidase cleaves sialic acid residues on infected cell surfaces, and without it viral particles cannot bud off. The drug blocks this step and reduces viral spread.

Indications

Influenza

First line

First-line antiviral for influenza in adults and children. RCTs show that starting treatment within 48 hours of symptom onset shortens illness by 1–2 days and reduces complication risk. In hospitalized patients and high-risk groups – pregnant, elderly, immunocompromised – treatment is started even beyond 48 hours.

Sources

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

COVID-19

Not recommended

Not effective against COVID-19. Oseltamivir inhibits neuraminidase, which SARS-CoV-2 lacks. The virus uses spike protein and ACE2 receptor for cell entry – an entirely different mechanism. Early oseltamivir prescriptions during COVID were driven by diagnostic uncertainty when influenza had not been ruled out.

Sources

Practical notes

Timing and administration

Take twice daily for 5 days. Taking with food reduces nausea but does not affect bioavailability. Start as early as possible – ideally within 48 hours. In children, the dose is weight-based. For post-exposure prophylaxis – 75 mg once daily for 10 days.

Common myths

Myth: 'oseltamivir doesn't work, Cochrane proved it'. Fact: the 2014 Cochrane review did find limited impact on complications, but the original RCTs were not powered for that endpoint. Meta-analyses of observational data show reduced mortality in hospitalized patients. CDC, , and still recommend oseltamivir for influenza treatment.

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Official sources

Direct links to regulator labels. Open in a new tab.

AEMPS / CIMA

Spanish Medicines Information Centre (CIMA)

EMA

European Medicines Agency

Label dated: 05/22/2014

FDA / DailyMed

FDA — DailyMed Drug Labels

Label dated: 01/30/2023

Safety

Contraindications

Hypersensitivity to oseltamivir

Serious adverse effects

Neuropsychiatric events in adolescents – delirium, abnormal behavior, hallucinations (rare, predominantly in Japanese cohorts)
Anaphylaxis and severe skin reactions (Stevens-Johnson syndrome – isolated cases)

Common adverse effects

Nausea
Vomiting
Headache

PregnancyFDA C

FDA category C. However, CDC and ACOG recommend oseltamivir for pregnant women with confirmed or suspected influenza. The benefit from reducing influenza complications during pregnancy outweighs the theoretical risk.

Breastfeeding

Compatible. Hale L2. Minimal transfer into milk (RID about 0.5%); plasma concentrations in the infant remain subtherapeutic. WHO, AEMPS and AAP consider it compatible with breastfeeding; influenza treatment in a nursing mother does not require interruption. Mild diarrhoea or nausea in the infant may occur and usually resolves without intervention.

Calculate RID Full profile on NIH LactMed ↗

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Frequently asked

What is Oseltamivir used for?

Oseltamivir is evaluated for the following indications with varying evidence strength: Influenza (evidence tier A), COVID-19 (evidence tier F). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Oseltamivir?

Common side effects of Oseltamivir (≥ 1 in 100): Nausea, Vomiting, Headache. See the Safety section for uncommon and serious reactions.

Is Oseltamivir safe during pregnancy?

FDA category C. FDA category C. However, CDC and ACOG recommend oseltamivir for pregnant women with confirmed or suspected influenza. The benefit from reducing influenza complications during pregnancy outweighs the theoretical risk.

Is Oseltamivir compatible with breastfeeding?

Who should not take Oseltamivir?

Oseltamivir is contraindicated in: Hypersensitivity to oseltamivir. Full list in the Safety section.

oseltamivir doesn't work, Cochrane proved it

the 2014 Cochrane review did find limited impact on complications, but the original RCTs were not powered for that endpoint. Meta-analyses of observational data show reduced mortality in hospitalized patients. CDC, IDSA, and WHO still recommend oseltamivir for influenza treatment.

Practical notes

Timing and administration

Common myths

Safety

Contraindications

Hypersensitivity to oseltamivir

Serious adverse effects

Neuropsychiatric events in adolescents – delirium, abnormal behavior, hallucinations (rare, predominantly in Japanese cohorts)
Anaphylaxis and severe skin reactions (Stevens-Johnson syndrome – isolated cases)

Common adverse effects

Nausea
Vomiting
Headache

PregnancyFDA C

Breastfeeding

Calculate RID Full profile on NIH LactMed ↗

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Frequently asked

What is Oseltamivir used for?

What are the side effects of Oseltamivir?

Common side effects of Oseltamivir (≥ 1 in 100): Nausea, Vomiting, Headache. See the Safety section for uncommon and serious reactions.

Is Oseltamivir safe during pregnancy?

Is Oseltamivir compatible with breastfeeding?

Who should not take Oseltamivir?

Oseltamivir is contraindicated in: Hypersensitivity to oseltamivir. Full list in the Safety section.

oseltamivir doesn't work, Cochrane proved it